Anti-Infectives

SRI has extensive expertise in infectious diseases and anti-infectives, conducting diverse market research globally and in the US. Our capabilities include big data analytics, detailed physician and patient research, market landscape and mapping development, and physician tracker studies.

We have also conducted field force feedback (F3) studies, market segmentations, ROI models for promotions, message effectiveness analysis, and conjoint or choice modeling studies to address a wide range of business questions in this therapeutic area. This comprehensive approach supports our clients’ strategic decision-making in infectious disease markets.